Sikeres tocilizumabkezelés HHV8-pozitív/ HIV-negatív Castleman-betegség plazmasejtes multicentrikus típusában

Translated title of the contribution: Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease

G. Müzes, Judit Csomor, F. Sípos

Research output: Contribution to journalArticle

Abstract

This is a case presentation of a HHV8-positive multicentric Castleman's disease (MCD) of plasma cell type. The patient failed to respond to combined immunosuppressive therapy and monoclonal anti-CD20 therapy. Interestingly, administration of anti-IL-6R antibody stabilized the disease and resulted in clearance of HHV8 from the involved lymph nodes.

Translated title of the contributionTocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease
Original languageHungarian
Pages (from-to)328-332
Number of pages5
JournalMagyar Onkologia
Volume60
Issue number4
Publication statusPublished - Nov 29 2016

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease'. Together they form a unique fingerprint.

  • Cite this